Skip to content
DataLookout
Menu

PERUSENCT07671599

Perioperative Use of Continuous Glucose Monitoring for Scheduled Cesarean Deliveries (PERUSE)

StatusRecruiting
PhaseNot specified
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Recruitment opened
    • Start date changed from estimate of Nov 2026 to Nov 6, 2026
    • Site details revised
  2. Notable Start date: Sep 2026 to Nov 2026
    • Eligibility criteria expanded, about 8 words
  3. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

interstitial glucose from CGM device
Timeframe: from pre-operative appointment through end of postpartum hospital stay, up to ten days

Secondary (1)

Number of surgical site infection

Arms and interventions

scheduled term c-section

Patients scheduled for term cesarean deliveries and who are screened eligible and consented will be administered a continuous glucose monitor prior to their c-section, and they will wear the device through their stay in the hospital.

Devices: Continuous Glucose Monitor

Sites

1 site in 1 country

  • Icahn School of Medicine at Mount SinaiNew York, New York, United States